PHIO PHARMACEUTICALS CORP. Stock Issued During Period, Value, Stock Dividend
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- PHIO PHARMACEUTICALS CORP. stock issued during period, value, stock dividend for the quarter ending 2013-06-30 was $2.40M, a 114.20% increase year-over-year.
- PHIO PHARMACEUTICALS CORP. stock issued during period, value, stock dividend for the quarter ending 2013-03-31 was $3.55M.
- PHIO PHARMACEUTICALS CORP. stock issued during period, value, stock dividend for the quarter ending 2012-12-31 was $918.00K.
- PHIO PHARMACEUTICALS CORP. stock issued during period, value, stock dividend for the quarter ending 2012-09-30 was $1.28M.
- PHIO PHARMACEUTICALS CORP. stock issued during period, value, stock dividend for fiscal 2012 was $3.31M.
| Period end | Stock Issued During Period, Value, Stock Dividend 3 month | Stock Issued During Period, Value, Stock Dividend 12 month |
|---|---|---|
| 2013-06-30 | $2.40M 10-Q · filed 2013-08-14 | $8.14M derived: sum of 4 quarters · filed 2013-08-14 |
| 2013-03-31 | $3.55M 10-Q · filed 2013-05-15 | $6.86M derived: sum of 4 quarters · filed 2013-08-14 |
| 2012-12-31 | $918.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-29 | $3.31M 10-K · filed 2013-03-29 |
| 2012-09-30 | $1.28M 10-Q · filed 2012-11-13 | |
| 2012-06-30 | $1.12M 10-Q · filed 2013-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |